Mehjabin Parkar, MD
Family Medicine · Sugar Land, TXNPI 1508068438
Payments from drug & device makers
Across 281 payments — averaging $13,710 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3.8M
- Novo Nordisk$788
- Lilly USA, LLC$572
- Nestle Healthcare Nutrition Inc.$415
- AbbVie$387
- AstraZeneca$363
- plus $2K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 22 | $3,847,565 |
| Novo Nordisk | 48 | $788 |
| Lilly USA, LLC | 32 | $572 |
| Nestle Healthcare Nutrition Inc. | 20 | $415 |
| AbbVie | 20 | $387 |
| AstraZeneca | 20 | $363 |
| Bayer | 17 | $335 |
| Boehringer Ingelheim | 12 | $261 |
| Pfizer | 11 | $206 |
| Aimmune Therapeutics, Inc. | 10 | $165 |
| Zynex Medical, Inc. | 1 | $144 |
| Merck | 8 | $134 |
| GSK | 4 | $118 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $115 |
| Eisai Inc. | 5 | $93 |
| Kowa Pharmaceuticals America, Inc. | 5 | $75 |
| Abbott | 3 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Corcept Therapeutics | 3 | $53 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $50 |
| Sanofi Pasteur Inc. | 2 | $49 |
| Shield Therapeutics Inc | 2 | $43 |
| Novartis | 3 | $42 |
| Exact Sciences | 2 | $40 |
| Melinta Therapeutics, LLC | 3 | $38 |
| Optinose US, Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Seqirus USA Inc | 1 | $27 |
| Boston Scientific | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
| Phadia US Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Althera Pharmaceuticals LLC | 1 | $13 |
How this compares
$3,852,464 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Sugar Land
- Wilner JeudySugar Land$6M
- Ronald PucilloSugar Land$5.1M
- John VanderzylSugar Land$3.8M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.